Federal award
ABBOTT RAPID DX NORTH AMERICA LLC
SPE2DE21F0149
Contract
Obligated and Ceiling
- Obligated (net)
- $63,031,863.77
- Ceiling (potential value, not spending)
- $63,031,863.77
- Current value
- $63,031,863.77
- Gross positive obligations
- $64,538,711.47
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- ABBOTT RAPID DX NORTH AMERICA LLC · P782RNU1NNK3
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- ABBOTT LABORATORIES · EF9EAJ1MF6U3
- Awarding agency
- Department of War · sub-agency 97AS · office SPE2DE
- Funding agency
- Department of War · sub-agency 97AS
- Product or service (PSC)
- 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- SPE2DE21F0149
- Parent vehicle (IDV PIID)
- SPE2DE20D0027
- Award type code
- C
- Actions
- 24 · Dec 30, 2020 to Apr 23, 2021
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History24
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Apr 23, 2021 | FY2021 | P00023 | D | −$1,476,028.41 | — |
| Apr 16, 2021 | FY2021 | P00022 | D | $2,517.00 | — |
| Apr 9, 2021 | FY2021 | P00021 | D | $1,350.20 | — |
| Apr 8, 2021 | FY2021 | P00020 | D | −$19,199.13 | — |
| Apr 1, 2021 | FY2021 | P00019 | D | $26,585.08 | — |
| Apr 1, 2021 | FY2021 | P00018 | D | −$11,620.16 | — |
| Mar 30, 2021 | FY2021 | P00017 | D | $9,900.42 | — |
| Mar 25, 2021 | FY2021 | P00016 | D | $183.40 | — |
| Mar 24, 2021 | FY2021 | P00015 | D | $78.80 | — |
| Mar 19, 2021 | FY2021 | P00014 | D | $183.40 | — |
| Mar 19, 2021 | FY2021 | P00013 | D | $1,483.40 | — |
| Mar 17, 2021 | FY2021 | P00012 | D | $1,966.80 | — |
| Mar 17, 2021 | FY2021 | P00011 | D | $10,392.77 | — |
| Mar 12, 2021 | FY2021 | P00009 | D | $183.40 | — |
| Mar 12, 2021 | FY2021 | P00010 | D | $12,800.00 | — |
| Mar 9, 2021 | FY2021 | P00008 | D | $2,166.80 | — |
| Mar 9, 2021 | FY2021 | P00007 | D | $0.00 | — |
| Mar 5, 2021 | FY2021 | P00006 | D | $0.00 | — |
| Mar 5, 2021 | FY2021 | P00005 | D | $0.00 | — |
| Mar 3, 2021 | FY2021 | P00004 | D | $0.00 | — |
| Feb 23, 2021 | FY2021 | P00003 | D | $0.00 | — |
| Feb 18, 2021 | FY2021 | P00002 | D | $0.00 | — |
| Feb 9, 2021 | FY2021 | P00001 | D | $0.00 | — |
| Dec 30, 2020 | FY2021 | 0 | — | $64,468,920.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.